World Class Health’s $8 million in seed funding was led by AlleyCorp. The company serves self-funded employers and offers access to a global centers of excellence network. The post World Class Health Snags $8M To Expand Global Centers of Excellence Network appeared first on MedCity News.
Startup Dimer Health offers proactive follow-ups and monitoring of patients at home to reduce the chances of patients returning to the hospital
The 2026 Medicare ACO landscape features expanded participation, new models like LEAD, and a focus on advanced payment tracks
Overcoming the systemic, structural and cultural issues that lead to poor nutrition is complex, making it even more essential for both private and public investment in food as health programs and policies that have been shown to be effective. The post Food as Health: Shifting from Treatment to Prevention of Diet-Related Disease appeared first on…
Using data on patients with a Veterans Affairs (VA) emergency department visit for a mental health condition, Costantini et al. (2025) finds that: …longer waiting times make it more likely that patients miss their follow-up mental health visit, consequently increasing the probability that they permanently disengage from care. A 1 standard deviation increase in wait…
Value-based care contracting is especially difficult for behavioral health providers, Taft Parsons III, chief psychiatric officer at CVS Health/Aetna, pointed out during a conference this week. The post Aetna Exec: Payers Need to Stop Making Behavioral Health Providers Jump Through Hoops In Order to Participate in Value-Based Care appeared first on MedCity News.
The $6.5 billion raised by biopharmaceutical companies in the first quarter of 2025 is down nearly 20% year over year, according to a report from GlobalData. The firm says investors continue to favor later-stage companies with clinical data. The post Investor Caution Leads to Dip in Biotech Financings, GlobalData Report Shows appeared first on MedCity…
This brief analyzes Medicaid enrollment and spending trends for FY 2025 and FY 2026, based on data provided by state Medicaid directors as part of the 25th annual survey of Medicaid directors.
Payers will often look to disease analogs when making pricing and coverage decisions. These disease analogs can inform the level of rebates, need for prior authorization/utilization management, and the drug’s cost sharing tier. Traditionally, however, disease analogs are selected on an ad hoc basis. In a recent JMCP paper titled “A structured approach for identifying…
The integration of the latest technologies improves diagnostic quality and accelerates treatment solutions, decreasing the time patients spend in discomfort or pain due to dental issues. The post More than a Third of the US has Dental Anxiety. Here’s How New Technology is Improving Patient Trust appeared first on MedCity News.